Navellier & Associates’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,296
| Closed | -$263K | – | 287 |
|
|
2022
Q4 | $263K | Buy |
9,296
+1,045
| +13% | +$29.6K | 0.05% | 226 |
|
|
2022
Q3 | $248K | Sell |
8,251
-61
| -0.7% | -$1.83K | 0.06% | 236 |
|
|
2022
Q2 | $282K | Sell |
8,312
-73
| -0.9% | -$2.48K | 0.06% | 236 |
|
|
2022
Q1 | $376K | Buy |
8,385
+123
| +1% | +$5.52K | 0.06% | 235 |
|
|
2021
Q4 | $382K | Buy |
+8,262
| New | +$382K | 0.06% | 243 |
|
|
2020
Q2 | – | Sell |
-20,800
| Closed | -$444K | – | 257 |
|
|
2020
Q1 | $444K | Hold |
20,800
| – | – | 0.1% | 147 |
|
|
2019
Q4 | $486K | Sell |
20,800
-7,532
| -27% | -$176K | 0.08% | 182 |
|
|
2019
Q3 | $596K | Sell |
28,332
-103,395
| -78% | -$2.18M | 0.1% | 166 |
|
|
2019
Q2 | $2.69M | Buy |
131,727
+8,289
| +7% | +$170K | 0.42% | 62 |
|
|
2019
Q1 | $3.47M | Buy |
123,438
+6,727
| +6% | +$189K | 0.54% | 44 |
|
|
2018
Q4 | $2.86M | Buy |
116,711
+23,127
| +25% | +$566K | 0.49% | 44 |
|
|
2018
Q3 | $3.48M | Buy |
+93,584
| New | +$3.48M | 0.45% | 63 |
|
|
2016
Q3 | – | Sell |
-10,000
| Closed | -$218K | – | 296 |
|
|
2016
Q2 | $218K | Sell |
10,000
-922
| -8% | -$20.1K | 0.03% | 220 |
|
|
2016
Q1 | $209K | Buy |
10,922
+108
| +1% | +$2.07K | 0.03% | 195 |
|
|
2015
Q4 | $303K | Buy |
+10,814
| New | +$303K | 0.03% | 168 |
|